Engineering the Next Oncolytic Viral Therapy for DIPG
A/Prof Marta Alonso and her research team at the University of Navarra, Spain.
On a global mission to beat brain cancer
Brain cancer kills more children in Australia than any other disease and more people under 40 than any other cancer. The worst type of brain cancer, GBM, is also the most common and has an average survival of only 15 months from diagnosis.
As a neurosurgeon I have operated on patients from all around the world who have been given no hope. At the Charlie Teo Foundation, we fund game-changing brain cancer research, offering hope of a better future for patients and families.
We need to start thinking differently to find a solution.
"Let’s do this together. We are going to get there. A world without brain cancer."
Dr Charlie Teo AM – Founder
Our Impact
Committed $15 million
to brain cancer research
in Australia and worldwide
Supporting 35 brain cancer
research projects
in adult & childhood brain cancer
Australia's leading dedicated
brain cancer charity
funding research globally
Runs a lean & efficient charity model. We are transparent around our spending!
Committed over $14 million
to brain cancer research
in Australia and worldwide
Supporting 30+ brain cancer research projects in adult & childhood brain cancer
Australia's leading dedicated brain cancer charity funding research globally
Runs a lean & efficient charity model. We are transparent around our spending!
Thank you to our corporate partners
Your investment in our ground-breaking research is making a genuine difference to people impacted by brain cancer
Upcoming Events
Latest News
Imaging Technologies Revolutionise our Understanding of Brain Tumour Microenvironment
Prof. Johanna Joyce and her team at the University of Lausanne, Switzerland.
Pioneering blood test for non-invasive detection of Paediatric Brain Cancer
Craig Horbinski, M.D., PhD, director of Neuropathology at Northwestern Medicine, USA.